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Abstract Skeletal muscle regulates substrate choice accord-
ing to demand and availability and pyruvate dehydrogenase
(PDH) is central in this regulation. Circulating interleukin
(IL)-6 increases during exercise and IL-6 has been suggested
to increase whole body fat oxidation. Furthermore, IL-6 has
been reported to increase AMP-activated protein kinase
(AMPK) phosphorylation and AMPK suggested to regulate
PDHa activity. Together, this suggests that IL-6 may be in-
volved in regulating PDH. The aim of this study was to
investigate the effect of a single injection of IL-6 on PDH
regulation in skeletal muscle in fed and fasted mice. Fed and
16–18 h fasted mice were injected with either 3 ng·g−1 re-
combinant mouse IL-6 or PBS as control. Fasting markedly
reduced plasma glucose, muscle glycogen, muscle PDHa
activity, as well as increased PDK4 mRNA and protein con-
tent in skeletal muscle. IL-6 injection did not affect plasma
glucose or muscle glycogen, but increased AMPK and ACC
phosphorylation and tended to decrease p38 protein content in
skeletal muscle in fasted mice. In addition IL-6 injection
reduced PDHa activity in fed mice and increased PDHa
activity in fasted mice without significant changes in PDH-
E1α phosphorylation or PDP1 and PDK4 mRNA and protein
content. The present findings suggest that IL-6 contributes to
regulating the PDHa activity and hence carbohydrate oxida-
tion, but the metabolic state of the muscle seems to determine
the outcome of this regulation. In addition, AMPK and p38
may contribute to the IL-6-mediated PDH regulation in the
fasted state.
Keywords IL-6 . Pyruvate dehydrogenase activity . AMPK .
p38 . Skeletal muscle
Introduction
Skeletal muscle has an exceptional ability to adjust the sub-
strate choice during fasting and exercise according to the
substrate availability [9, 24]. During prolonged exercise, skel-
etal muscle first oxidizes blood glucose and stored glycogen,
but an increasing fraction of the energy is derived from fat
oxidation as the exercise proceeds [37, 38]. This ensures that
exercise can continue, although at a lower exercise intensity.
Similarly, fasting is associated with a switch in substrate
oxidation from carbohydrates to fat markedly increasing sur-
vival without food intake.
The pyruvate dehydrogenase complex (PDC) is central in
the regulation of substrate choice in skeletal muscle. PDC
converts pyruvate into acetyl CoA thereby linking glycolysis
with the citric acid cycle and represents the only entry for
carbohydrate-derived substrate into the mitochondria for oxi-
dation. PDC is composed of several copies of three catalytic
enzymes, which includes the pyruvate dehydrogenase (PDH)-
E1α. Fasting has been shown to downregulate the activity of
PDH in the active form (PDHa) [43]. In addition, PDHa
activity increases with exercise [37], but declines towards
resting level as the exercise duration exceeds 2 h [25, 39].
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Although PDHa activity can be allosterically regulated [2],
phosphorylation/dephosphorylation of the α subunit of PDH-
E1 is thought to be the mainmechanism regulating the activity
of PDH. Phosphorylation and concomitant inactivation of
PDH is catalyzed by pyruvate dehydrogenase kinases
(PDK), and dephosphorylation and concomitant activation
of PDH is catalyzed by pyruvate dehydrogenase phosphatases
(PDP). The decrease in PDHa activity during fasting seems to
be due to increased PDK4 protein and decreased PDP1 protein
content in the muscle [43], while the reduction during
prolonged exercise does not appear to be caused by increased
PDK4 protein content but may be due to increased PDK
activity as previously reported [39]. The underlying mecha-
nisms initiating the regulation of PDH during prolonged ex-
ercise remains unresolved.
Interleukin (IL)-6 is a myokine released from contracting
muscle during exercise and suggested to exert autocrine,
paracrine and endocrine effects [23]. The plasma IL-6 con-
centration has been reported to increase in both humans and
mice during prolonged exercise [20, 21]. In humans, the
increase in plasma IL-6 concentration during exercise is de-
tectable after about 2 hour with moderate exercise intensity
and increases further with exercise duration [12, 34], while an
increase in plasma IL-6 has been detected already after 30 min
of intense exercise in mice [20]. Recombinant IL-6 has been
shown to increase free fatty acid release from myotubes [1]
and increase fat oxidation in human skeletal muscle in vivo
[35, 42]. In addition, IL-6 has been reported to increase AMP-
activated protein kinase (AMPK) phosphorylation in rat skel-
etal muscle [13], and rodent studies suggest that AMPK may
regulate PDH [17, 32]. Furthermore, IL-6 has been shown to
increase phosphorylation of the stress mitogen activated pro-
tein (MAP) kinase p38 in incubated human muscle [6] and
MAPK p38 has been demonstrated to be involved in the
regulation of IL-6 transcription [36]. Furthermore, previous
findings suggest an association between increased p38 phos-
phorylation and decreased PDHa activity in cardiomyocytes
[29]. Together this suggests that IL-6 could be involved in
regulating the substrate choice of muscle either by directly
regulating PDH or potentially via AMPK and p38. Therefore,
the aim of the present studywas to examine the isolated effects
of a single injection of recombinant mouse (rm) IL-6 on PDH
regulation in mouse skeletal muscle. As IL-6 normally is
elevated during exercise in the presence of severe metabolic
challenge, the effect of IL-6 injection was determined in both
the fed and fasted state.
Methods
Mice Female C57BL/6 mice (Taconic, Lille Skensved, Den-
mark) 8 weeks of age were used in the study. Female mice were
used because a previous study showed no indications of
gender-specific regulation of PDH [14] and because regular
oestrous cycle has been reported to be absent in the majority of
female mice housed in large groups [41]. The mice had ad
libitum access to water and normal chow diet (Altromin 1324,
Brogaarden, Lynge, Denmark) and had a 12:12 light–dark
cycle. The experiments were approved by the Danish Animal
Experimental expectorate (license no. 2009, 561 1607) and
complied by the European Convention for the protection of
vertebrate animals used for experiments and other scientific
purpose (Council of Europe no. 123. Strasbourg, France 1985).
Experimental setup The mice were housed individually 24 h
before initiation of the experiment and divided into two groups
either fed or fasted for 16–18 h. The mice were given an
intraperitoneal injection of either phosphate-buffered saline
(PBS) or rm IL-6 (3 ng·g−1) dissolved in PBS. The mice were
euthanized by cervical dislocation 30 or 60 min after the injec-
tion. Quadriceps muscles were removed and frozen in liquid
nitrogen. Trunk blood was collected in EDTA containing tubes
and plasma was collected after centrifugation at 2,600×g ,
15 min, 4 °C. Muscle and plasma samples were stored at −80 °C.
Plasma glucose and plasma IL-6 Plasma glucose concentra-
tion was analyzed fluorometrically [18]. The plasma IL-6
concentration was determined using Meso Scale Discovery
(Rockville, MD, USA) as described by the manufacturer.
Muscle glycogen Muscle samples were hydrolyzed in 1 M
HCl and the muscle glycogen concentration was determined
fluorometrically as glycosyl units as previously described [22].
RNA isolation and reverse transcription Quadriceps muscles
from the mice were crushed in liquid nitrogen to ensure
homogeneity of each sample. RNA was isolated using a
guanidinium thiocyanate phenol-choloroform method as pre-
viously described [4, 26] except that the samples were ho-
mogenized using a Tissue LyserII (Qiagen, Hilden, Germany).
Reverse transcription was performed using the Superscript II
RNase H- system (Invitrogen, Carlsbad, CA, USA) as previ-
ously described [26].
Real time PCR mRNA content was determined by use of the
5′ fluorogenic nuclease assay with TaqMan probes (ABI
PRISM 7900 Sequence Detection System; Applied
Biosystems, Foster City, CA, USA) as previously described
[19]. Primer and probe sequences are given in Table 1. Cycle
threshold values reflecting the content of a specific mRNA
were converted to an arbitrary amount by use of a standard
curve, constructed from a serial dilution of a representative
sample run together with the unknown samples. For each
sample the amount of target cDNAwas normalized to the total
single stranded (ss)DNA content in the sample determined by
OliGreen as previously described [19].
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SDS-PAGE and western blotting Crushed quadriceps muscles
were homogenized using a Tissue LyserII (Quagen, Hilden,
Germany) and muscle lysate was prepared as previously de-
scribed [25]. The protein content in each sample was determined
using the bicinchoninic acidmethod (Pierce, Rockford, IL, USA).
Protein content and protein phosphorylation were deter-
mined in muscle lysates using pre casted gels (Biorad, Hercu-
les, CA, USA) or hand-casted gels and SDS-PAGE and West-
ern blotting as previously described [16, 25] with primary
polyclonal antibodies against Signal Transducer and Activator
of Transcription (STAT)3 (9139; Cell Signaling Technology,
Berverly, MA, USA), p38 (9212; Cell Signaling Technology),
acetyl CoA carboxylase (ACC; P0397; DAKO, Glostrup, Den-
mark), AMPKα2, PDP1, PDK4, and PDH-E1α (provided by
Professor Graham Hardie, Dundee University, Dundee, UK)
and primary phospho-specific antibodies against STAT3 Tyr705
and AMPK Thr172 (9138 and 2535, respectively, Cell Signal-
ing Technology), ACC Ser79 (07-303; Millipore, Bedford,
USA), PDH-E1α site 1 (Ser293), site 2 (Ser300), and site 4
(Ser295; provided by Professor Graham Hardie). Secondary
antibodies used were all species-specific horseradish peroxi-
dase conjugated immunoglobulin (DakoCytomation, Glostrup,
Denmark). The bands were visualized with ECL reagent
(Millipore, Billerica, MA, USA) in a photo image system and
quantified (Carestream Health, Rochester, NY, USA). The
PDP1 protein band was verified with recombinant protein.
GAPDH protein was determined (2118, Cell Signaling Tech-
nology) and showed no changes between groups.
PDHa activity PDHa activity was determined in muscle ho-
mogenates as previously described [3, 5, 25, 31]. PDHa
activity in each sample was adjusted to the total creatine
content in the homogenate as previously described [33].
Statistics Values are presented as means±SE. Two-way
ANOVA tests were used to evaluate the effect of fasting and
IL-6 injection by testing within each time point and within each
condition. The data were log transformed if equal variance test
failed. If a main effect was observed, the Student–Newman–
Keuls post hoc test was used to locate differences. In addition, a
Student’s t test was used to evaluate the effect of IL-6 within a
given time point and condition. Differences were considered
significant whenP <0.05 and a tendency is reported for 0.05≤P
<0.1. The statistical tests were performed using SigmaPlot 11.0.
Results
Plasma IL-6
The plasma IL-6 concentration was measured to examine the
time course of plasma IL-6 after an IL-6 injection. The IL-6Ta
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injection increased (P <0.05) the plasma IL-6 concentration
9.5-fold in fedmice and 40-fold in fastedmice 30min after the
injection relative to the PBS injected mice. After 60 min, the
plasma IL-6 concentration was still elevated (P <0.05) 5-fold
in fed mice and 12-fold in fasted mice relative to the PBS-
injected mice (Fig. 1a).
In the IL-6-injected mice, the plasma IL-6 level was 2.4-
fold higher (P <0.05) in fasted than fed mice at 30 min, which
may be due to differences in blood volume or differences in
uptake or removal of IL-6 from the blood. In the PBS-injected
mice, fasting reduced (P <0.05) the plasma IL-6 concentration
to 60 % compared with the fed mice (Fig. 1a). However, of
notice is that such effect was not present at 30 min suggesting
that additional factors have contributed to the effect observed
at 60 min (Fig. 1a).
STAT3 phosphorylation
STAT3 phosphorylation was determined in skeletal muscle to
confirm that IL-6 injections induced IL-6-mediated intracel-
lular responses.
IL-6 injection increased (P <0.05) STAT3 Tyr705 phos-
phorylation in skeletal muscle 2-fold in fed mice and 2.3-fold
in fasted mice relative to PBS at 30 min after injection. At
60 min, the injection of IL-6 increased (P <0.05) the STAT
Tyr705 phosphorylation in skeletal muscle 2.2-fold in fed and
2-fold in fasted mice relative to PBS-injected mice (Fig. 1b).
In the IL-6-injected mice, STAT3 Tyr705 phosphorylation
was at 30 min 1.8-fold higher (P <0.05) in the fasted than the
fed mice (Fig. 1b).
Plasma glucose
The blood glucose concentration wasmeasured to describe the
metabolic status of the mice during fasting and after IL-6
injection. The IL-6 injection did not change the plasma
glucose concentration relative to PBS, neither in the fed nor
the fasted mice (Fig. 2a).
Plasma glucose concentration was at approximately 8 mM
in fed mice independent of injection and decreased (P <0.05)
to approximately 5 mM in the fasted mice both in the PBS and
the IL-6-injected mice (Fig. 2a).
Muscle glycogen
Muscle glycogen concentration was measured to describe the
metabolic status of the mice during fasting and after IL-6
injection. There was a main effect (P <0.05) of IL-6 injection
on muscle glycogen content at 30 min, but no changes were
observed at 60 min (Fig. 2b).
Fasting reduced (P <0.05) the muscle glycogen content
with 50–60 % compared with the fed mice independent of
injection (Fig. 2b).
Signaling
AMPK, ACC and p38 phosphorylation were determined to
examine the effects of IL-6 on intracellular signaling in skel-
etal muscle.
AMPK
There were no effects of IL-6 on AMPK Thr172 phosphoryla-
tion in skeletal muscle of the fed mice. In the fasted mice, the
IL-6 injection increased (P <0.05) AMPK Thr172 phosphory-
lation 1.3-fold relative to PBS at 60 min (Fig. 3a).
In addition, at 30 min fasting tended to increase (0.05≤P <
0.1) AMPK Thr172 phosphorylation 1.2-fold in the PBS-
injected mice and in the IL-6-injected mice fasting increased
(P <0.05) AMPK phosphorylation 1.2-fold relative to fed
(Fig. 3a).
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ACC
The IL-6 injection did not change ACC Ser79 phosphorylation
in skeletal muscle of the fed mice. In the fasted mice, the IL-6
injection increased (P <0.05) the ACC phosphorylation 1.4-
fold in the fastedmice relative to the PBSmice at 60min when
using a t test (Fig. 3b).
In line with the AMPK results, 30 min after injection, ACC
Ser79 phosphorylation was 1.5-fold higher (P <0.05) in fasted
than in fed mice injected with PBS and tended to be 1.4-fold
higher (0.05≤P <0.1) in fasted than in fed mice injected with
IL-6 (Fig. 3b).
p38
The IL-6 injection did not change the phosphorylation level of
p38 when normalized to p38 protein content in skeletal mus-
cle of fed or fasted mice (Fig. 3c). However, the IL-6 injection
tended to decrease (0.05≤P <0.1) the p38 protein content with
70–85 % compared with PBS injection both at 30 and 60 min
(Fig. 3c, d).
In addition, p38 protein content was 1.5- to 1.8-fold higher
(P <0.05) in the fasted than the fed mice both at 30 and 60min
(Fig. 3d).
IL-6 mRNA
IL-6 injection did not change the mRNA content of IL-6 in
skeletal muscle of the fed and fasted mice (Fig. 4).
Furthermore, fasting increased (P <0.05) the IL-6 mRNA
level 1.8- to 2.0-fold at 30 and 60 min but only in the IL-6-
injected mice (Fig. 4).
PDH regulation
The mRNA and protein levels of PDK4 and PDP1 were
determined together with the PDHa activity and PDH
phosphorylation to examine the effects of fasting and IL-6
injection on PDH regulation.
PDK4 and PDP1 mRNA
IL-6 injection did not change the PDK4 mRNA content in
skeletal muscle of the fed and fasted mice (Fig. 5a), but the
PDP1 mRNA content tended to be higher (0.05≤P <0.1)
60 min after IL-6 injection than PBS (Fig. 5c).
Fasting increased (P <0.05) the PDK4mRNA content 5- to
6-fold Fig. 5a) and decreased (P <0.05) the PDP1 mRNA
content with 60 % (Fig. 5c).
PDK4 and PDP1 protein
The PDK4 protein content in skeletal muscle increased (P <
0.05) 1.6-fold in the fasted mice relative to the fed with no
effect of IL-6 injection (Fig. 5b). The PDP1 protein content
did not change with IL-6 injection or with fasting (Fig. 5d).
PDHa activity
The PDHa activity in skeletal muscle tended overall to be
lower (0.05≤P <0.1) in the IL-6-injected fed mice than the
PBS injected fed mice. In addition, the PDHa activity was in
the fed mice at 30 min 30 % lower (P <0.05) after IL-6
injection than after PBS when using a t test. IL-6 injection
in the fasted mice increased (P <0.05) PDHa activity 2-fold at
30 min and 1.8-fold at 60 min.
Furthermore, fasting overall reduced (P <0.05) the PDHa
activity in skeletal muscle to 15–30 % of the level in fed mice
(Fig. 6a).
PDH-E1α phosphorylation
Overall, the effects on PDH-E1α phosphorylation were sim-
ilar for the investigated PDH-E1α phosphorylation sites. IL-6
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injection did not change PDH-E1α phosphorylation in the fed
or fasted mice (Fig. 6b–d).
Fasted mice had 1.7- to 2.1-fold higher (P <0.05) PDH-
E1α phosphorylation than fed mice independent of injection
(Fig. 6b–d).
Discussion
The main finding of the present study is that IL-6 injections
regulated PDHa activity in mouse skeletal muscle but differ-
ently in fed and fasted conditions. In addition, an IL-6 injec-
tion increased AMPK and ACC phosphorylation in mouse
skeletal muscle only in the fasted state. This indicates that
AMPK did not mediate the IL-6-induced reduction in PDHa
activity in the fed state but could potentially be involved in the
increase in the fasted state. Furthermore, IL-6 reduced p38
protein content in skeletal muscle in the fasted state, making it
possible that p38 could play a role in the observed IL-6-
induced change in PDHa activity in the fasted state.
Skeletal muscle regulates substrate choice according to
availability and is therefore capable of coping with major
metabolic changes during exercise and fasting [2, 38]. The
previous findings that IL-6 infusion in humans enhances fat
oxidation in skeletal muscle [35] and that plasma IL-6 is
increased during prolonged exercise [21] suggest that IL-6
could be involved in regulating substrate choice during exer-
cise. The observation that the increase in plasma IL-6 after the
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IL-6 injection in the present study was similar to the increase
reported after a single exercise bout in mice [20], shows that
the obtained IL-6 levels are at a physiologically relevant level.
Furthermore, the increase in phosphorylation of the IL-6
signaling marker STAT3 in skeletal muscle in the current
study demonstrates that IL-6 elicited an intracellular response
in skeletal muscle at the investigated time points. Together this
suggests that the present experimental setting can be used as a
model to investigate the isolated effects of IL-6 on PDH
regulation in skeletal muscle during exercise. In addition, the
pronounced fasting-induced decrease in muscle glycogen and
plasma glucose concentration shows that the fasted mice were
severely metabolically challenged. This provides a model to
investigate the potential impact of the metabolic state for IL-6-
mediated effects on PDH regulation in skeletal muscle.
The observation that IL-6 downregulated PDHa activity in
skeletal muscle in the fed state is in accordance with the
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previously shown IL-6-induced fat oxidation [35, 42] and
suggests that IL-6 may contribute to regulating substrate
choice during exercise towards increased skeletal muscle fat
oxidation in part by regulating PDH. The previous observa-
tion that an IL-6 injection increased AMPK phosphorylation
in rat skeletal muscle suggests that AMPK may be mediating
IL-6-induced regulation [13]. Furthermore, AMPKα2 knock-
out (KO) mice have been reported to exhibit an enhanced
exercised-induced increase in PDHa activity [17] and the
AMPK activator AICAR has been shown to increase PDK4
mRNA in skeletal muscle [11]. Together this suggests that IL-
6 mediates effects on PDH via AMPK. However, the present
observation that AMPK and ACC phosphorylations were
unaffected by IL-6 injections in the fed state does not support
that AMPK was directly involved in the observed IL-6-
induced reduction in PDHa activity in the fed state.
The present findings that IL-6 elicited an increase in skel-
etal muscle PDHa activity in the fasted state, despite the IL-6-
induced downregulation in the fed state, indicate that the
metabolic status influences the impact of IL-6 on PDH regu-
lation. As IL-6 injections in the fasted state were associated
with increased AMPK and ACC phosphorylation at 60 min, it
is possible that AMPK was involved in the IL-6-mediated
PDH regulation at this time point. However, this potential
effect of AMPK on PDH is opposite of the apparent AMPK-
mediated suppression of the exercise-induced PDHa activa-
tion, as suggested from the more marked exercise-induced
increase in PDHa activity in AMPKα2 KO than wild-type
(WT) mice [17]. However, the AMPKα2 KO mice in the
previous study had lower muscle glycogen and plasma glu-
cose after exercise than WT [17]. Therefore, the more marked
PDH activation in AMPKα2 KO mice may not be due to the
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lack of AMPK, but rather that the AMPKα2 KO mice were
more metabolically challenged than WT as also suggested in
the previous study [17, 25]. Furthermore, as low muscle
glycogen has been suggested to enhance exercise-induced
IL-6 expression and release from skeletal muscle [12] the
more marked PDHa activation in the AMPKα2 KO mice in
the previous study [17] may have been due to increased IL-6
levels rather than lack of AMPK. This possibility is supported
by the previous finding that AICAR incubation elicited a
higher IL-6 release from AMPK kinase dead mouse muscle
than WT muscle [7] and is also in line with the present IL-6-
mediated increase in PDHa activity in the fasted state. In
addition, the present findings that IL-6 injection tended to
reduce p38 protein content in the fasted state may suggest that
p38 potentially have contributed to the observed IL-6-induced
increase in PDHa activity, because increased p38 phosphory-
lation has been associated with decreased PDHa activity in
cardiomyocytes [29]. Of notice, the IL-6-induced downregu-
lation of p38 protein only 30 and 60 min after injection is
surprisingly fast and indicates that IL-6 either inhibits p38
synthesis or increases degradation.While a previous study has
shown that IL-6 regulates p38 phosphorylation in skeletal
muscle [40], no previous studies have to our knowledge
reported IL-6-mediated regulation of p38 protein. However,
it may be speculated that IL-6 mediates the regulation of p38
mRNA targeting miRNA’s leading to reduced translation of
p38, but this remains to be determined.
As PDHa activity is known to be regulated by changes in
NADH/NAD+, ATP/ADP, and acetyl CoA/acetyl [9, 24, 30],
it may be speculated that IL-6 has mediated effects via chang-
es in one of these ratios. Indeed a previous study has shown
that IL-6 incubation of rat EDL decreased the ATP concentra-
tion and elevated the AMP concentration suggesting that IL-6-
induced changes in nucleotides could play a role in the ob-
served IL-6-mediated regulation of PDHa activity in the pres-
ent study. An IL-6-induced decrease in ATP and increase in
AMP concentrations would be expected to be associated with
an enhanced PDHa activity, which is in accordance with the
changes observed in the fasted state in the present study.
However, changes in ATP, ADP and AMP as well as
NADH/NAD+ and acetyl CoA/acetyl are thought to exert
effects on PDHa activity through changes in PDH-E1α phos-
phorylation [10, 24]. Because IL-6 injections did not affect
PDH-E1α phosphorylation significantly neither in the fed nor
the fasted state in the present study, changes in these param-
eters do not appear to be a likely mechanism for the observed
IL-6-induced effects on PDH regulation.
It should be noted that IL-6 induced an increase in PDHa
activity when PDHa activity was at a very low level due to the
fasting conditions. This means that the PDHa activity after IL-
6 injections in the fasted state still was much lower than the
level of PDHa activity after IL-6 induced downregulation of
PDH in the fed state. The mechanism behind such a switch is
unknown and additional studies are needed to answer this.
The observations that PDHa activity, PDH-E1α phosphoryla-
tion, PDK4 and PDP1 mRNA, as well as PDK4 protein were
markedly changed by fasting in the present study are in
accordance with previous studies [27, 28]. This shows that
differences could be detected at the mRNA, protein phosphor-
ylation, and activity level. Furthermore, the finding that
fasting elicited 90% reduction in PDHa activity in PBS, while
IL-6 injection only resulted in a 30 % reduction demonstrates
that the effect of 18 h of fasting is much more marked than a
single IL-6 injection. This may indicate that IL-6 only con-
tributes to the regulation of PDH for example by sensitizing
PDHa to the metabolic needs of the cell. However, it may also
be worth noting that the magnitude of reduction in PDHa
activity in response to IL-6 injection is quite similar to the
reduction previously reported in the exercise-induced increase
in PDHa activity in human skeletal muscle, when muscle
glycogen had been lowered prior to exercise [15]. This makes
it possible that an enhanced IL-6 release contributed to the
smaller exercise-induced increase in PDHa activity when
muscle glycogen was reduced in the previous study [15].
Moreover, the similar magnitude of change in the present
study and the previous human study indicates that the ob-
served change in PDHa activity with IL-6 injections is similar
to changes observed in a physiological setting in humans [15].
PDH-E1α phosphorylation is known to be the dominant
regulatory mechanism determining PDHa activity. The un-
changed PDH-E1α phosphorylation with IL-6 injection in
the present study indicates that the observed changes in PDHa
activity was not due to changes in phosphorylation level. Such
discrepancy between PDHa activity and PDH-E1α phosphor-
ylation has previously been reported in resting human and
mouse skeletal muscle [14, 25], although the previous studies
observed changes in PDH-1Eα phosphorylation without
changes in PDHa activity. As effects of PDK and PDP ex-
pression and/or activity would be expected to influence the
phosphorylation level of PDH-E1α, these PDH regulatory
proteins do not seem to be in play in the IL-6-mediated effects.
This suggestion is in line with the unaffected PDK4 and PDP1
protein level with a single IL-6 injection. Furthermore, the
unchanged plasma glucose concentration and unchanged
muscle glycogen in the fed state upon IL-6 injection (although
an overall difference was observed for muscle glycogen)
indicate that IL-6 did not change the carbohydrate availability
in the fed state. Thus, it seems unlikely that changes in the
metabolic state have contributed to the observed downregula-
tion of PDHa activity. It may therefore be speculated that IL-6
has elicited alternative mechanisms like changes in acetylation
state, because several acetylation sites have been identified on
PDH [8].
Based on the previous findings that reduced muscle glyco-
gen has been shown to enhance IL-6 transcription in human
skeletal muscle [12] it may be expected that fasting would
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elevate muscle IL-6mRNA levels. However, the finding that a
fasting-induced elevation in IL-6 mRNA only was observed
in IL-6 injected mice suggests that low glycogen is not suffi-
cient to increase IL-6 mRNA, and that IL-6 exerts a positive
feedback on the expression of IL-6 when muscle glycogen
levels are low. In addition, the IL-6 induced intracellular
signaling observed both in the fed and fasted state while IL-
6 mRNA only increased significantly in the fasted state in the
present study, may suggest that an IL-6-mediated effect on IL-
6 expression requires a factor which is only available when
muscle glycogen is low. As p38 has been implicated in regu-
lating IL-6 expression [36] the observed fasting-induced in-
crease in p38 protein content may have contributed to the
elevated IL-6 mRNA. However, the observed reduction in
p38 protein content with IL-6 injection does not support this
possibility. Hence, the mechanism behind the fasting-induced
increase in skeletal muscle IL-6 mRNA only when IL-6 was
injected remains to be determined.
In conclusion, a single IL-6 injection reduces PDHa activity
in mouse skeletal muscle in the fed state and increases PDHa
activity in the fasted state. This suggests that IL-6-mediated
PDH regulation contributes to regulating substrate choice, but
that the metabolic state determines the outcome. IL-6 appears
to regulate PDHa activity without clear changes in PDH-E1α
phosphorylation and AMPK and p38 may be involved in the
IL-6-mediated PDH regulation in the fasted state.
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